FDA-cleared profile

MAGNETOM Vida; MAGNETOM Lumina; MAGNETOM Aera; MAGNETOM Skyra; MAGNETOM Prisma; MAGNETOM Prisma fit

Siemens Medical Solutions USA, Inc. · MRI · FDA-cleared (510(k))

Authorized purpose: MAGNETOM Aera, Skyra, Prisma, Prisma fit, Vida, and Lumina with syngo MR XA60A are 1.5T and 3T magnetic resonance diagnostic systems that produce cross-sectional images, spectroscopic images or spectra, and derived physical parameters of the head, body, or extremities for trained-physician interpretation. K231560 adds or migrates model-specific hardware and software, including Deep Resolve Boost HASTE and Deep Resolve Boost EPI Diffusion on Vida and Lumina.

Clinical role
The systems acquire and reconstruct MRI examinations within the scanner workflow. Deep Resolve Boost uses deep-learning reconstruction to denoise and sharpen accelerated HASTE or EPI diffusion acquisitions on the supported Vida and Lumina configurations; other XA60A functions vary by model and include new or modified pulse sequences, physiologic logging, Open Recon, MR Fingerprinting, beat sensing, and myExam angiography assistance.
Images and patients
MRI · Multi-region
Key limitation
Keep in mind: Features are model- and license-specific: the K231560 summary lists Deep Resolve Boost HASTE and EPI Diffusion for Vida and Lumina, not for every named system. FDA did not require a new clinical trial for substantial equivalence, did not report demographic attributes for the AI datasets, and did not define clinical subgroups. Product-family studies are single-center, include Siemens-affiliated authors, and show that accelerated reconstruction can change ADC values or produce a minority of images rated worse, so each protocol and quantitative use requires local validation.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: MAGNETOM Aera, Skyra, Prisma, Prisma fit, Vida, and Lumina with syngo MR XA60A are 1.5T and 3T magnetic resonance diagnostic systems that produce cross-sectional images, spectroscopic images or spectra, and derived physical parameters of the head, body, or extremities for trained-physician interpretation. K231560 adds or migrates model-specific hardware and software, including Deep Resolve Boost HASTE and Deep Resolve Boost EPI Diffusion on Vida and Lumina.
  • Which images or clinical context are in scope?Modality: MRI Anatomy or clinical context: Multi-region Input: Raw MRI acquisition data, patient and examination demographics, user-selected protocols and pulse-sequence parameters, coil and patient setup, optional physiologic signals, and contrast-agent information when applicable. Deep Resolve inputs are undersampled or lower-signal MRI data from supported HASTE, TSE, or EPI diffusion workflows.
  • Who uses it?Intended users: Healthcare professionals familiar with and responsible for magnetic resonance image acquisition and post-processing operate the systems; trained physicians interpret the images, spectra, and derived physical parameters. The AI reconstruction features support image production and do not autonomously diagnose a patient.
  • What does the software produce?Output: Transverse, sagittal, coronal, or oblique cross-sectional images; spectroscopic images or spectra; and derived physical parameters for trained-physician interpretation. Supported Deep Resolve workflows output denoised and sharpened reconstructed images, while Open Recon and research reconstruction outputs require configuration-specific review before clinical use.
  • What is its most important limitation?Key limitation: Features are model- and license-specific: the K231560 summary lists Deep Resolve Boost HASTE and EPI Diffusion for Vida and Lumina, not for every named system. FDA did not require a new clinical trial for substantial equivalence, did not report demographic attributes for the AI datasets, and did not define clinical subgroups. Product-family studies are single-center, include Siemens-affiliated authors, and show that accelerated reconstruction can change ADC values or produce a minority of images rated worse, so each protocol and quantitative use requires local validation.

Clinical takeaway. Clinical role: MAGNETOM Aera, Skyra, Prisma, Prisma fit, Vida, and Lumina with syngo MR XA60A are 1.5T and 3T magnetic resonance diagnostic systems that produce cross-sectional images, spectroscopic images or spectra, and derived physical parameters of the head, body, or extremities for trained-physician interpretation. K231560 adds or migrates model-specific hardware and software, including Deep Resolve Boost HASTE and Deep Resolve Boost EPI Diffusion on Vida and Lumina.

Evidence takeaway. Evidence from the reviewed source record: K231560 provides unusually detailed exact-submission AI dataset provenance but no new clinical trial, demographic breakdown, subgroup analysis, or public diagnostic-accuracy endpoint. The cited and later product-family studies support protocol-specific image-quality and acquisition-time benefits while also showing ADC shifts and a minority of worse-rated images. These findings support local protocol evaluation, not a blanket claim across six models, every anatomy, or every quantitative workflow.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
MAGNETOM Aera, Skyra, Prisma, Prisma fit, Vida, and Lumina with syngo MR XA60A are 1.5T and 3T magnetic resonance diagnostic systems that produce cross-sectional images, spectroscopic images or spectra, and derived physical parameters of the head, body, or extremities for trained-physician interpretation. K231560 adds or migrates model-specific hardware and software, including Deep Resolve Boost HASTE and Deep Resolve Boost EPI Diffusion on Vida and Lumina.
  • Exact FDA submission
  • Checked 2026-09-02
Workflow role
The systems acquire and reconstruct MRI examinations within the scanner workflow. Deep Resolve Boost uses deep-learning reconstruction to denoise and sharpen accelerated HASTE or EPI diffusion acquisitions on the supported Vida and Lumina configurations; other XA60A functions vary by model and include new or modified pulse sequences, physiologic logging, Open Recon, MR Fingerprinting, beat sensing, and myExam angiography assistance.
  • Exact FDA submission
  • Checked 2026-09-02
Required input
Raw MRI acquisition data, patient and examination demographics, user-selected protocols and pulse-sequence parameters, coil and patient setup, optional physiologic signals, and contrast-agent information when applicable. Deep Resolve inputs are undersampled or lower-signal MRI data from supported HASTE, TSE, or EPI diffusion workflows.
  • Exact FDA submission
  • Checked 2026-09-02
Output and clinician action
Transverse, sagittal, coronal, or oblique cross-sectional images; spectroscopic images or spectra; and derived physical parameters for trained-physician interpretation. Supported Deep Resolve workflows output denoised and sharpened reconstructed images, while Open Recon and research reconstruction outputs require configuration-specific review before clinical use.
  • Exact FDA submission
  • Checked 2026-09-02
Care setting
Professional MRI facilities with the MR safety, siting, patient screening, contrast governance, protocol management, image interpretation, service, and quality-assurance controls required for 1.5T or 3T diagnostic systems. MAGNETOM Aera may also be configured as Aera Mobile, and the systems may support imaging during compatible interventional procedures.
  • Exact FDA submission
  • Checked 2026-09-02
Intended users
Healthcare professionals familiar with and responsible for magnetic resonance image acquisition and post-processing operate the systems; trained physicians interpret the images, spectra, and derived physical parameters. The AI reconstruction features support image production and do not autonomously diagnose a patient.
  • Exact FDA submission
  • Checked 2026-09-02
Limitations
Features are model- and license-specific: the K231560 summary lists Deep Resolve Boost HASTE and EPI Diffusion for Vida and Lumina, not for every named system. FDA did not require a new clinical trial for substantial equivalence, did not report demographic attributes for the AI datasets, and did not define clinical subgroups. Product-family studies are single-center, include Siemens-affiliated authors, and show that accelerated reconstruction can change ADC values or produce a minority of images rated worse, so each protocol and quantitative use requires local validation.
  • Product family
  • Checked 2026-09-02
Evidence summary
K231560 provides unusually detailed exact-submission AI dataset provenance but no new clinical trial, demographic breakdown, subgroup analysis, or public diagnostic-accuracy endpoint. The cited and later product-family studies support protocol-specific image-quality and acquisition-time benefits while also showing ADC shifts and a minority of worse-rated images. These findings support local protocol evaluation, not a blanket claim across six models, every anatomy, or every quantitative workflow.
  • Product family
  • Checked 2026-09-02

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
K231560 provides unusually detailed exact-submission AI dataset provenance but no new clinical trial, demographic breakdown, subgroup analysis, or public diagnostic-accuracy endpoint. The cited and later product-family studies support protocol-specific image-quality and acquisition-time benefits while also showing ADC shifts and a minority of worse-rated images. These findings support local protocol evaluation, not a blanket claim across six models, every anatomy, or every quantitative workflow.
  • Public source
  • Product family
  • Checked 2026-09-02
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Deep Resolve Boost EPI Diffusion training and validation data

1000000 slices, more than

  • EndpointDisclosed training and validation dataset scale
  • PopulationMRI data spanning body parts, contrasts, fat-suppression techniques, orientations, and 1.5T and 3T field strengths; demographics were not recorded
  • Tested versionDeep Resolve Boost EPI Diffusion in K231560

Abdominal diffusion acquisition-time reduction

39.5 % reduction calculated from reported means

  • EndpointMean DL DWI acquisition time of 216.87 seconds versus 358.69 seconds for conventional DWI
  • Population74 consecutive patients undergoing 3T abdominal MRI
  • Tested versionDeep-learning EPI diffusion reconstruction on a Siemens 3T system; exact commercial software build not reported in the abstract

Single-breath-hold deep-learning HASTE acquisition time

16 seconds

  • EndpointAcquisition time versus 90 seconds for conventional multiple-breath-hold HASTE and 240 seconds for respiratory-triggered BLADE
  • Population66 patients undergoing 1.5T liver MRI
  • Tested versionDeep-learning HASTE research implementation on a Siemens 1.5T system; exact commercial software build not reported in the abstract

Knee DL-TSE maximum scan-time reduction

52 % faster, up to

  • EndpointAccelerated research DL-TSE versus conventional TSE, with at least 45% higher image resolution
  • Population232 paired conventional and deep-learning knee TSE image sets acquired on a 3T MAGNETOM Vida
  • Tested versionResearch DL-TSE sequence on MAGNETOM Vida 3T; not identified as the exact K231560 commercial build

K231560 nonclinical verification, image-quality assessment, and AI training and validation summary

  • DesignManufacturer software verification and validation, sample clinical-image review, comparison imaging, physiologic-logging verification, coil bench testing, and AI dataset characterization
  • Population1.5T and 3T MRI data spanning multiple body regions, contrasts, fat-suppression techniques, and orientations; demographics were not recorded and clinical subgroups were not defined
  • Scopeexact submission
  • Tested versionMAGNETOM Aera, Skyra, Prisma, Prisma fit, Vida, and Lumina with syngo MR XA60A
  • IndependenceSponsor or vendor study

K231560

FDA reports that the verification and validation supported substantial equivalence. No new clinical test was conducted; sample clinical images and publications were supplied, and public diagnostic-accuracy, subgroup, site, reader, and patient-outcome results are not reported.

Clinical feasibility of accelerated diffusion weighted imaging of the abdomen with deep learning reconstruction

  • DesignRetrospective single-center intraindividual comparison of conventional and deep-learning reconstructed abdominal DWI, with two-radiologist qualitative review and ADC measurements
  • Population74 consecutive patients undergoing 3T abdominal MRI
  • Scopeproduct family
  • Tested versionDeep-learning EPI diffusion reconstruction on a Siemens 3T system; exact commercial software build not reported in the abstract
  • Samplen=74
  • Sites1
  • IndependenceSponsor or vendor study

PMID 35797791

Three authors were affiliated with Siemens. DL DWI was faster and scored higher for qualitative image quality, but liver and focal-lesion ADC values were lower than with conventional DWI, requiring local quantitative validation.

Diagnostic Confidence and Feasibility of a Deep Learning Accelerated HASTE Sequence of the Abdomen in a Single Breath-Hold

  • DesignRetrospective single-center comparison of deep-learning single-breath-hold HASTE, conventional multiple-breath-hold HASTE, and respiratory-triggered BLADE with two-reader qualitative assessment
  • Population66 patients undergoing 1.5T liver MRI
  • Scopeproduct family
  • Tested versionDeep-learning HASTE research implementation on a Siemens 1.5T system; exact commercial software build not reported in the abstract
  • Samplen=66
  • Sites1
  • IndependenceSponsor or vendor study

PMID 33208596

Two authors were affiliated with Siemens. The 16-second sequence was successfully acquired in all patients, with diagnostic confidence and lesion assessment similar to BLADE but overall image quality statistically inferior to BLADE.

Evaluation of deep-learning TSE images in clinical musculoskeletal imaging

  • DesignProspective clinical comparison of one repeated research DL-TSE knee sequence per consenting patient against the corresponding conventional clinical TSE sequence, with blinded reporting-radiologist preference assessment
  • Population232 paired knee TSE image sets acquired on one 3T MAGNETOM Vida
  • Scopeproduct family
  • Tested versionResearch DL-TSE sequence on MAGNETOM Vida 3T; not identified as the exact K231560 commercial build
  • Samplen=232
  • Sites1
  • IndependenceSponsor or vendor study

PMID 38837669

The image-pair count is used because the abstract does not separately state the unique-participant count. Siemens affiliations were present. Smaller structures were rated worse in 21 of 232 pairs, and the study did not use an independent diagnostic reference standard.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
FDA recall Z-2658-2025 includes MAGNETOM Lumina model 11344916 because ice may block the magnet venting system. A quench could then produce pressure buildup, rupture the helium containment system, and leak helium into the scan room. FDA lists the recall as open and classified. FDA recall Z-2659-2025 includes MAGNETOM Prisma model 10849582 because ice may block the magnet venting system. A quench could then produce pressure buildup, rupture the helium containment system, and leak helium into the scan room. FDA lists the recall as open and classified. FDA recall Z-2660-2025 includes MAGNETOM Skyra model 10432915 because ice may block the magnet venting system. A quench could then produce pressure buildup, rupture the helium containment system, and leak helium into the scan room. FDA lists the recall as open and classified. FDA recall Z-2667-2025 includes MAGNETOM Vida model 11060815 because ice may block the magnet venting system. A quench could then produce pressure buildup, rupture the helium containment system, and leak helium into the scan room. FDA lists the recall as open and classified.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04

Each published event was manually matched to the exact FDA submission and affected product or version; a recall does not establish an AI-algorithm defect or current site exposure unless the event states that scope.

recall: Z-2658-2025

Open, Classified

2025-09-30

Native K231560 and exact Lumina model match. This is a magnet, quench-venting, and facility-safety issue, not a Deep Resolve defect; verify serial-number scope, inspection or correction status, emergency routes, and the current Siemens safety notice.

recall: Z-2659-2025

Open, Classified

2025-09-30

Native K231560 and exact Prisma model match. This is a magnet, quench-venting, and facility-safety issue, not a Deep Resolve defect; verify serial-number scope, inspection or correction status, emergency routes, and the current Siemens safety notice.

recall: Z-2660-2025

Open, Classified

2025-09-30

Native K231560 and exact Skyra model match. This is a magnet, quench-venting, and facility-safety issue, not a Deep Resolve defect; verify serial-number scope, inspection or correction status, emergency routes, and the current Siemens safety notice.

recall: Z-2667-2025

Open, Classified

2025-09-30

Native K231560 and exact Vida model match. This is a magnet, quench-venting, and facility-safety issue, not a Deep Resolve defect; verify serial-number scope, inspection or correction status, emergency routes, and the current Siemens safety notice. The four reviewed K231560 records do not identify Aera or Prisma fit.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Pricing is recorded, but no exact-product procurement price with a stated offer scope is published in the reviewed sources.

Public pricing
No public list price for a K231560 MAGNETOM system, XA60A upgrade, or Deep Resolve license was stated on the Siemens product and education pages reviewed. Procurement should obtain a configuration-specific capital and lifecycle quote that separates scanner or upgrade price, coils and options, construction and siting, applications and service training, service coverage, cybersecurity support, software upgrades, and downtime commitments.
  • Product family
  • Checked 2026-09-02

Reimbursement

Reimbursement
CMS NCD 220.2 addresses coverage of medically necessary MRI and MRA services performed on FDA-authorized equipment within its labeling; it does not establish separate payment for a MAGNETOM scanner, syngo MR XA60A, or Deep Resolve. Coverage, coding, payment, and prior authorization remain examination-, payer-, site-, and patient-specific.
  • Service-level, not product-specific
  • Checked 2026-09-02

No product-specific code

No separate named-product payment identified in CMS NCD 220.2

Medicare · United States · Effective 2018-04-10

The NCD provides MRI and MRA coverage context and does not assign payment to XA60A or Deep Resolve. Verify the ordered examination, medical necessity, current code set, site of service, payer contract, and local coverage rules.

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Raw MRI acquisition data, patient and examination demographics, user-selected protocols and pulse-sequence parameters, coil and patient setup, optional physiologic signals, and contrast-agent information when applicable. Deep Resolve inputs are undersampled or lower-signal MRI data from supported HASTE, TSE, or EPI diffusion workflows.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-02 · K231560 FDA 510(k) decision summary

  2. Routing

    Source context, not route validation: K231560 identifies DICOM PS 3.1 through PS 3.20 (2021e) as a conformance standard. Siemens publishes syngo MR XA60A DICOM conformance statements for the relevant 1.5T and 3T MAGNETOM systems, and the XA60 operator manual covers patient and study management, DICOM node configuration, encrypted DICOM connections, imports, exports, archiving, and interoperability versus enhanced-image export profiles.

    Scope: Exact product version. Use the conformance statement for the installed model and build, then test worklist, patient reconciliation, series and derived-image metadata, enhanced versus interoperability export, routing, archive, storage commitment, failure recovery, and downstream quantitative behavior end to end.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-02 · K231560 FDA 510(k) decision summary · syngo MR XA60A DICOM conformance statements for 1.5T MAGNETOM systems · syngo MR XA60A DICOM conformance statements for 3T MAGNETOM systems · syngo MR XA60 Operator Manual: MR System Administration

  3. AI processing

    Source context, not route validation: On-premises 1.5T or 3T MRI systems running syngo MR XA60A, with modified host computers on all named models and model-specific changes to the measurement and reconstruction system, coils, beat sensor, or image-calculation hardware. Deployment may be fixed-site or an Aera Mobile configuration. Vida product-family planning data list a 70 cm bore, 7.35-ton operating weight, and a 31 square meter minimum room, but those figures must not be transferred to the other models.

    Scope: Product family. Require a model- and serial-number-specific site plan covering shielding, structural load, power, cooling, quench venting, emergency routes, network, coils, licenses, acceptance testing, downtime, service access, and mobile-operation controls where applicable.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-02 · K231560 FDA 510(k) decision summary · MAGNETOM Vida 3T MRI scanner

  4. Returned objects

    Source context, not route validation: Transverse, sagittal, coronal, or oblique cross-sectional images; spectroscopic images or spectra; and derived physical parameters for trained-physician interpretation. Supported Deep Resolve workflows output denoised and sharpened reconstructed images, while Open Recon and research reconstruction outputs require configuration-specific review before clinical use.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-02 · K231560 FDA 510(k) decision summary

  5. Viewer/worklist/report

    Unresolved route: Transverse, sagittal, coronal, or oblique cross-sectional images; spectroscopic images or spectra; and derived physical parameters for trained-physician interpretation. Supported Deep Resolve workflows output denoised and sharpened reconstructed images, while Open Recon and research reconstruction outputs require configuration-specific review before clinical use.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-02 · K231560 FDA 510(k) decision summary

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
On-premises 1.5T or 3T MRI systems running syngo MR XA60A, with modified host computers on all named models and model-specific changes to the measurement and reconstruction system, coils, beat sensor, or image-calculation hardware. Deployment may be fixed-site or an Aera Mobile configuration. Vida product-family planning data list a 70 cm bore, 7.35-ton operating weight, and a 31 square meter minimum room, but those figures must not be transferred to the other models.
  • Product family
  • Checked 2026-09-02

Require a model- and serial-number-specific site plan covering shielding, structural load, power, cooling, quench venting, emergency routes, network, coils, licenses, acceptance testing, downtime, service access, and mobile-operation controls where applicable.

Integration
K231560 identifies DICOM PS 3.1 through PS 3.20 (2021e) as a conformance standard. Siemens publishes syngo MR XA60A DICOM conformance statements for the relevant 1.5T and 3T MAGNETOM systems, and the XA60 operator manual covers patient and study management, DICOM node configuration, encrypted DICOM connections, imports, exports, archiving, and interoperability versus enhanced-image export profiles.
  • Exact product version
  • Checked 2026-09-02

Use the conformance statement for the installed model and build, then test worklist, patient reconciliation, series and derived-image metadata, enhanced versus interoperability export, routing, archive, storage commitment, failure recovery, and downstream quantitative behavior end to end.

Security
The syngo MR XA60 administration manual documents role-based authorization, explicit authentication controls, certificate-based encrypted DICOM connections, HTTPS options, patient-data minimization for export, audited remote Expert-i sessions, local audit records, and optional encrypted forwarding to an external Syslog server. It warns against exposing HTTP or HTTPS ports directly to the Internet and notes that the syngo audit trail does not capture actions performed in Windows or third-party software.
  • Exact product version
  • Checked 2026-09-02

Confirm which controls are enabled on the installed system, obtain the current security white paper and component inventory, restrict privileged roles, validate certificates and remote access, forward and retain audit records, document patch governance, and assess operating-system and third-party logging gaps.

Training
The XA60 operator manual requires personnel to have the necessary expertise and read the complete operator manual before use. Siemens Academy lists model-specific Vida and Lumina XA60 upgrade training and MR Deep Resolve content, while the US MRI education portfolio offers protocol preparation, onsite education, classroom and virtual training, and protocol-building workshops for technologists.
  • Product family
  • Checked 2026-09-02

Document role-based competency for operators, radiologists, physicists, MR safety personnel, clinical administrators, IT administrators, and service staff, including Deep Resolve artifact recognition, quantitative-measurement effects, fallback, recall actions, and post-upgrade revalidation.

Monitoring
syngo MR XA60 provides a Message Viewer for component, timestamp, severity, and message details; SaveLog collection; a configurable audit trail for patient-data access, network transfer, logon, security changes, software updates, service sessions, and DICOM-node changes; local audit storage; status monitoring; and optional secure Syslog forwarding. The manual documents local audit-log size thresholds and automatic deletion, making external retention and alerting operational requirements.
  • Exact product version
  • Checked 2026-09-02

Monitor system and reconstruction errors, DICOM failures, protocol and software changes, Deep Resolve settings, image-quality complaints, quantitative drift, repeats and aborted scans, acquisition and room time, downtime, audit forwarding, storage thresholds, service actions, and completion of open recall corrections by model and serial number.

Model and feature configuration matrix

K231560 covers six scanner families with syngo MR XA60A, but hardware and software changes differ by model. Deep Resolve Boost HASTE and EPI Diffusion are listed for Vida and Lumina, while GRE_PC, physiologic logging, Open Recon, MR Fingerprinting, beat sensing, myExam angiography assistance, and the Aera Flex Loop Large coil have different model coverage.

exact submission · checked 2026-09-02

Tie every clinical, interoperability, security, and service claim to scanner model, serial number, field strength, XA60A build, hardware revision, coil, and licensed option before contracting or validation.

Deep Resolve protocol validation

The FDA summary and clinical literature support denoising, sharpening, and faster supported acquisitions, but the literature also reports ADC shifts and some worse-rated image pairs.

product family · checked 2026-09-02

Validate each anatomy, sequence, acceleration, coil, contrast condition, field strength, pathology mix, artifact pattern, lesion task, and quantitative measurement with radiologist and physicist approval.

DICOM and data export controls

Siemens provides XA60A conformance statements for the relevant 1.5T and 3T systems. The operator manual distinguishes interoperability and enhanced export profiles and provides data-minimization options for removable-media export.

exact product version · checked 2026-09-02

Test local RIS, worklist, PACS, VNA, viewers, quantitative tools, routing, archive, and recovery using both routine and derived images. Confirm whether older destinations preserve enhanced MR content.

Security and audit operations

XA60 documents role controls, authentication, DICOM encryption, HTTPS, remote-session auditing, local audit records, and secure Syslog forwarding, together with known Windows and third-party audit gaps.

exact product version · checked 2026-09-02

Test the installed configuration against hospital identity, certificate, segmentation, remote-access, SIEM, time-synchronization, vulnerability, patch, backup, retention, and incident-response requirements.

Throughput measurement

Product-family studies report material sequence-level time savings, but they do not establish room-time, daily-capacity, staffing, or financial gains for a new site.

product family · checked 2026-09-02

Measure acquisition time and total room time separately by examination type, including setup, coils, contrast, repeats, reconstruction latency, turnover, staffing, demand, and whether saved minutes produce additional completed examinations.

Training and change control

Public Siemens resources include XA60 upgrade, model-specific, Deep Resolve, onsite, virtual, and protocol-building education options.

product family · checked 2026-09-02

Include training scope, protected education time, competency records, protocol ownership, post-upgrade regression testing, user acceptance, and refresher support in the implementation plan and contract.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K231560
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
MRI
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-02
Anatomy
Multi-region
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-02
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2023-10-23
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
23Fields reviewed
14Source classes checked
20Screened PubMed leads
10Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains 20 PubMed and 10 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 20 PubMed and 10 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. 4 FDA recall candidates were manually reviewed: 4 published and 0 rejected as a neighboring or otherwise inapplicable version. Native FDA recall identifiers produced 4 postmarket candidate records; 4 have been reviewed (4 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, peer reviewed publication, trial registry, vendor product page, vendor operator manual, vendor interoperability, vendor training, reimbursement policy, fda device recall, literature index, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed

19 sources - 3 history items

Source ledger

  1. K231560 FDA 510(k) decision summary

    U.S. Food and Drug Administration - Published 2023-10-23 - Accessed 2026-09-02

    Scope: purpose, modality, anatomy, intendedUsers, careSetting, workflowRole, input, output, limitations, deployment, evidenceSummary, evidenceMetrics, implementationCapabilities

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. FDA recall Z-2658-2025: MAGNETOM Lumina (DE). Model Number: 11344916.

    U.S. Food and Drug Administration - Published 2025-09-30 - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  4. FDA recall Z-2659-2025: MAGNETOM Prisma. Model Number: 10849582.

    U.S. Food and Drug Administration - Published 2025-09-30 - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  5. FDA recall Z-2660-2025: MAGNETOM Skyra (DE). Model Number: 10432915. 510(k) Numbers: K101347, K111242, K123510, K133435, K140253, K141977, K142515, K153343, K173592, K202014, K231560.

    U.S. Food and Drug Administration - Published 2025-09-30 - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  6. FDA recall Z-2667-2025: MAGNETOM Vida (DE). Model Number: 11060815. 510(k): K170396, K173617, K181433, K183254, K192924, K203443, K213693, K213805, K220425, K231560.

    U.S. Food and Drug Administration - Published 2025-09-30 - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  7. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  8. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  9. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  10. Clinical feasibility of accelerated diffusion weighted imaging of the abdomen with deep learning reconstruction

    European Journal of Radiology - Published 2022-06-30 - Accessed 2026-09-02

    Scope: evidenceSummary, evidenceStudy, evidenceMetrics, implementationCapabilities

  11. Diagnostic Confidence and Feasibility of a Deep Learning Accelerated HASTE Sequence of the Abdomen in a Single Breath-Hold

    Investigative Radiology - Published 2021-05-01 - Accessed 2026-09-02

    Scope: evidenceSummary, evidenceStudy, evidenceMetrics, implementationCapabilities

  12. Evaluation of deep-learning TSE images in clinical musculoskeletal imaging

    Journal of Medical Imaging and Radiation Oncology - Published 2024-06-05 - Accessed 2026-09-02

    Scope: evidenceSummary, evidenceStudy, evidenceMetrics, implementationCapabilities

  13. MAGNETOM Vida 3T MRI scanner

    Siemens Healthineers - Accessed 2026-09-02

    Scope: productFamily, deployment, pricingResearch, currentCommercialContext

  14. syngo MR XA60 Operator Manual: MR System Administration

    Siemens Healthineers - Published 2023-10-01 - Accessed 2026-09-02

    Scope: integration, deployment, security, training, monitoring, implementationCapabilities

  15. syngo MR XA60A DICOM conformance statements for 1.5T MAGNETOM systems

    Siemens Healthineers - Accessed 2026-09-02

    Scope: integration, implementationCapabilities, softwareVersion

  16. syngo MR XA60A DICOM conformance statements for 3T MAGNETOM systems

    Siemens Healthineers - Accessed 2026-09-02

    Scope: integration, implementationCapabilities, softwareVersion

  17. MAGNETOM Vida and Vida Fit learning catalog

    Siemens Healthineers Academy - Accessed 2026-09-02

    Scope: training, softwareVersion, implementationCapabilities

  18. Magnetic Resonance Imaging education portfolio

    Siemens Healthineers - Accessed 2026-09-02

    Scope: training, pricingResearch, implementationCapabilities

  19. National Coverage Determination 220.2: Magnetic Resonance Imaging

    Centers for Medicare & Medicaid Services - Published 2018-04-10 - Accessed 2026-09-02

    Scope: reimbursement, mriCoverageContext

Research history

  1. K231560 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K260746

S-scan Open (100001800)

Esaote, S.p.A.

Authorized purpose: S-scan Open is an Esaote MR system for diagnostic image acquisition, reconstruction, display, and professional interpretation within the labeled scanner, coil, sequence, and anatomy scope.

Modality
MRI
Anatomy
Multi-region
Decision
2026-03-27
FDA-cleared K252379

AIR Recon DL

Ge Medical Systems, LLC

Authorized purpose: AIR Recon DL adds a deep-learning phase-correction and reconstruction option to supported GE 1.5T, 3T, and 7T MR workflows for all labeled anatomies and ages to reduce noise or ringing and support image quality or scan-time choices.

Modality
MRI
Anatomy
Multi-region
Decision
2025-12-23
FDA-cleared K252838

MAGNETOM Sola; MAGNETOM Altea; MAGNETOM Sola Fit; MAGNETOM Viato.Mobile; MAGNETOM Vida; MAGNETOM Lumina; MAGNETOM Vida Fit; MAGNETOM Flow.Elite; MAGNETOM Flow.Neo; MAGNETOM Flow.Rise

Siemens Healthcare GmbH

Authorized purpose: The listed MAGNETOM 1.5T and 3T MRI systems produce cross-sectional images, spectroscopic images or spectra, and derived physical parameters of the head, body, and extremities for trained-physician interpretation and can support imaging during MR-compatible interventions.

Modality
MRI
Anatomy
Multi-region
Decision
2025-12-19

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history